|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
Quinidine: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Quinidine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
 |
|
$750.00 |
| |
|
|
|
Sirolimus: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Sirolimus testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Tacrolimus: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Tacrolimus testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Theophylline: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Theophylline testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Tobramycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Tobramycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Topirimate: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Topirimate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Valproic Acid: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Valproic Acid testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Vancomycin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Vancomycin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
C4: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of C4 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Free Light Chains: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Free Light Chains testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Haptoglobin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Haptoglobin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
IgA: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of IgA testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
IgE Specific: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of IgE Specific testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
IgE Total: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of IgE Total testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
IgG: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of IgG testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
IgM: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of IgM testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Immunofixation: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Immunofixation testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Prealbumin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Prealbumin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
|